Kanitinib in Treating Patients With Advanced Solid Tumors
Clinical trial NCT02916095 · COMPLETED
Trial details
- NCT number
- NCT02916095
- Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2020-01-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.